← Insiders

EGHT

VENTE TOTALE: 107 085 titres (~194 241,48 $ US)

Insiders
Burton Andrew F.
Total bought
Total sold
$194,241
Last activity
2026-09-11
Last synced
2026-09-16 10:16:14 Synced via automated research pipeline

Insider holdings as a share of total assets aren't available for this company.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

Market snapshot

Signal

Bearish signal Scored 2026-09-16

EGHT shows early signs of an operational turnaround with a return to profitability in FY2026, but the financial foundation remains fragile with thin margins, negative interest coverage, and a tightening current ratio.

The first sentence of the analysis written for EGHT on 2026-09-16 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Financial ratios

MetricTrend2026-03-312025-03-312024-03-312023-03-312022-03-31
Gross Profit Margin64.6%67.9%69.1%69.1%61.2%
Ebit Margin2.9%0.7%-3.3%-3.3%-24.0%
Ebitda Margin7.3%6.2%3.2%3.2%-16.1%
Operating Profit Margin2.6%2.1%-3.8%-3.8%-24.2%
Pretax Profit Margin0.5%-3.4%-8.8%-8.8%-27.5%
Continuous Operations Profit Margin0.2%-3.8%-9.3%-9.3%-27.5%
Net Profit Margin0.2%-3.8%-9.3%-9.3%-27.5%
Bottom Line Profit Margin0.2%-3.8%-9.3%-9.3%-27.5%
Current Ratio1.0881.2051.4361.1881.439
Quick Ratio1.0881.2051.4361.1881.439
Solvency Ratio0.0660.021-0.031-0.028-0.172
Cash Ratio0.4840.5200.6740.4850.476
Price To Earnings Ratio166.000-9.524-4.786-7.446-8.123
Price To Earnings Growth Ratio-1.5850.1520.0000.117-0.758
Forward Price To Earnings Growth Ratio-1.5850.1520.0000.117-0.758
Price To Earnings Diluted Ratio166.000-9.524-4.786-7.446-8.123
Price To Earnings Diluted Growth Ratio-1.5850.1520.0000.117-0.758
Price To Book Ratio1.5592.1243.1835.0557.826
Price To Sales Ratio0.3110.3630.4450.6932.236
Price To Free Cash Flow Ratio4.3915.1825.23114.898140.286
Price To Operating Cash Flow Ratio4.1024.0844.10910.35241.151
Debt To Assets Ratio0.5600.6010.6320.6760.590
Debt To Equity Ratio2.5303.3574.6855.6942.947
Debt To Capital Ratio0.7170.7700.8240.8510.747
Long Term Debt To Capital Ratio0.6580.7350.8010.8110.710
Financial Leverage Ratio4.5215.5907.4158.4264.991
Working Capital Turnover Ratio28.53113.01612.30011.4465.334
Operating Cash Flow Ratio0.2890.3760.4580.2120.181
Operating Cash Flow Sales Ratio0.0760.0890.1080.0670.054
Free Cash Flow Operating Cash Flow Ratio0.9340.7880.7860.6950.293
Debt Service Coverage Ratio2.4091.0100.4870.189-4.511
Interest Coverage Ratio-1.0660.527-0.693-0.693-6.798
Short Term Operating Cash Flow Coverage Ratio1.4215.4820.0000.7750.000
Operating Cash Flow Coverage Ratio0.1500.1550.1650.0860.065
Capital Expenditure Coverage Ratio15.1614.7194.6633.2771.415
Dividend Paid And Capex Coverage Ratio15.1614.7194.6633.2771.415
Dividend Payout Ratio0.0000.0000.0000.0000.000
Enterprise Value Multiple9.45113.21829.75141.746-18.245

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. higher lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 64.6% -3.3% -1.8%
Ebit Margin 2.9% 2.2% 8.3%
Ebitda Margin 7.3% 1.1% 6.6%
Operating Profit Margin 2.6% 0.4% 8.0%
Pretax Profit Margin 0.5% 3.8% 10.1%
Continuous Operations Profit Margin 0.2% 4.0% 10.2%
Net Profit Margin 0.2% 4.0% 10.2%
Bottom Line Profit Margin 0.2% 4.0% 10.2%
Current Ratio 1.088 -0.117 -0.183
Quick Ratio 1.088 -0.117 -0.183
Solvency Ratio 0.066 0.044 0.094
Cash Ratio 0.484 -0.037 -0.044
Price To Earnings Ratio 166.000 175.524 138.776
Price To Earnings Growth Ratio -1.585 -1.737 -1.170
Forward Price To Earnings Growth Ratio -1.585 -1.737 -1.170
Price To Earnings Diluted Ratio 166.000 175.524 138.776
Price To Earnings Diluted Growth Ratio -1.585 -1.737 -1.170
Price To Book Ratio 1.559 -0.565 -2.390
Price To Sales Ratio 0.311 -0.052 -0.499
Price To Free Cash Flow Ratio 4.391 -0.790 -29.606
Price To Operating Cash Flow Ratio 4.102 0.018 -8.658
Debt To Assets Ratio 0.560 -0.041 -0.052
Debt To Equity Ratio 2.530 -0.827 -1.312
Debt To Capital Ratio 0.717 -0.054 -0.065
Long Term Debt To Capital Ratio 0.658 -0.076 -0.085
Financial Leverage Ratio 4.521 -1.069 -1.668
Working Capital Turnover Ratio 28.531 15.515 14.405
Operating Cash Flow Ratio 0.289 -0.087 -0.014
Operating Cash Flow Sales Ratio 0.076 -0.013 -0.003
Free Cash Flow Operating Cash Flow Ratio 0.934 0.146 0.235
Debt Service Coverage Ratio 2.409 1.399 2.492
Interest Coverage Ratio -1.066 -1.593 0.679
Short Term Operating Cash Flow Coverage Ratio 1.421 -4.061 -0.115
Operating Cash Flow Coverage Ratio 0.150 -0.005 0.026
Capital Expenditure Coverage Ratio 15.161 10.442 9.314
Dividend Paid And Capex Coverage Ratio 15.161 10.442 9.314
Dividend Payout Ratio 0.000 0.000 0.000
Enterprise Value Multiple 9.451 -3.766 -5.733

Key metrics

MetricTrend20262025202420232022
Market cap$228.5M$259.5M$324.6M$505.0M$1.43B
Enterprise value$506.2M$581.7M$685.9M$962.5M$1.87B
EV / Sales0.69x0.81x0.94x1.32x2.94x
EV / Op. cash flow9.09x9.15x8.68x19.73x54.02x
EV / Free cash flow9.73x11.62x11.05x28.39x184.15x
EV / EBITDA9.45x13.22x29.75x41.75x-18.25x
Net debt / EBITDA5.18x7.32x15.67x19.84x-4.35x
Current ratio1.09x1.21x1.44x1.19x1.44x
Income quality33.81x-2.34x-1.17x-0.67x-0.20x
Graham number$1
Graham net-net-$3-$3-$4-$5-$5
Tax burden46.7%113.1%105.7%105.7%99.8%
Interest burden16.6%-502.0%265.1%265.1%114.8%
Working capital$17.0M$34.6M$75.3M$43.2M$84.1M
Invested capital$423.4M$455.5M$517.6M$527.5M$621.6M
Return on assets0.2%-4.0%-8.9%-8.0%-19.3%
Operating ROA2.8%2.1%-3.5%-3.2%-19.4%
Return on tangible assets0.5%-7.9%-16.8%-14.4%-34.0%
Return on equity1.1%-22.3%-66.3%-67.7%-96.2%
Return on invested capital1.7%2.8%-4.6%-4.0%-20.9%
Return on capital employed4.0%3.0%-4.7%-4.5%-21.4%
Earnings yield0.7%-10.5%-20.8%-13.4%-12.3%
Free cash flow yield22.8%19.3%19.1%6.7%0.7%
Capex / Op. cash flow6.6%21.2%21.4%30.5%70.7%
Capex / Depreciation20.3%34.3%35.9%28.5%50.5%
Capex / Sales0.5%1.9%2.3%2.0%3.8%
SG&A / Sales46.6%48.5%52.7%57.6%67.7%
R&D / Sales15.4%17.2%18.7%18.7%17.6%
Stock comp / Sales0.0%5.6%8.5%12.3%20.9%
Intangibles / Total assets50.4%49.7%46.7%44.4%43.4%
Days sales outstanding28d25d30d31d33d
Days payables outstanding51d73d79d76d73d
Operating cycle28d25d30d31d33d
Cash conversion cycle-23d-47d-50d-45d-40d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — up down versus then.

Change over 1 year

Valuation
Market cap ▼-11.9%EV / Sales ▼-15.4%EV / EBITDA ▼-28.5%EV / Op. cash flow ▼-0.068Earnings yield ▲+0.112
Profitability
Return on equity ▲+0.234Return on assets ▲+0.042Return on invested capital ▼-0.011Return on capital employed ▲+0.011Operating ROA ▲+0.007Income quality ▲+36.144Tax burden ▼-0.663
Efficiency
Days sales outstanding ▲+2.921Days payables outstanding ▼-21.302Operating cycle ▲+2.921Cash conversion cycle ▲+24.222Capex / Sales ▼-0.014R&D / Sales ▼-0.019
Balance-sheet strength
Current ratio ▼-0.117Net debt / EBITDA ▼-2.136Working capital ▼-17668000.000Invested capital ▼-32120000.000Intangibles / Total assets ▲+0.007

Change over 5 years

Valuation
Market cap ▼-84.0%EV / Sales ▼-76.6%EV / EBITDA ▲+151.8%EV / Op. cash flow ▼-44.933Earnings yield ▲+0.130
Profitability
Return on equity ▲+0.973Return on assets ▲+0.195Return on invested capital ▲+0.227Return on capital employed ▲+0.255Operating ROA ▲+0.222Income quality ▲+34.006Tax burden ▼-0.530
Efficiency
Days sales outstanding ▼-4.553Days payables outstanding ▼-21.907Operating cycle ▼-4.553Cash conversion cycle ▲+17.354Capex / Sales ▼-0.033R&D / Sales ▼-0.023
Balance-sheet strength
Current ratio ▼-0.351Net debt / EBITDA ▲+9.531Working capital ▼-67141000.000Invested capital ▼-198198000.000Intangibles / Total assets ▲+0.070

Employee count

Peer market caps

Congressional trades

Recent trades

DateRepresentativeTypeAmount
2020-03-10Tom MalinowskiPurchase$15,001 - $50,000

Recent news